Background: The structural modification of natural products with the aim to improve the anticancer activity is a popular current research direction. The pentacyclic triterpenoid compounds oleanolic acid (OA) and glycyrrhetinic acid (GA) are distributed widely in nature.Methods: In this study, various oleanolic acids and glycyrrhetinic acids were designed and synthesized by using the combination principle. The in vitro anticancer activities of new OA and GA derivatives were tested by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) method with SGC-7901 (gastric cancer), MCF-7 (breast cancer), Eca-109 (esophageal cancer), HeLa (cervical cancer), Hep-G2 (hepatoma cancer) and HSF (normal human skin fibroblast) cells.Results and conclusion: The screening results showed that the compound 3m presented the highest inhibitory activities against SGC-7901, MCF-7 and Eca-109 cell lines with IC50 values of 7.57 +/- 0.64 mu M, 5.51 +/- 0.41 mu M and 5.03 +/- 0.56 mu M, respectively. In addition, this compound also showed effective inhibition of Hep-G2 cells with an IC50 value of 4.11 +/- 0.73 mu M. Moreover, compound 5b showed the strongest inhibitory activity against Hep-G2 cells with an IC50 value of 3.74 +/- 0.18 mu M and compound 3l showed strong selective inhibition of the HeLa cells with the lowest IC50 value of 4.32 +/- 0.89 mu M. A series of pharmacology experiments indicated that compound 5b could induce Hep-G2 cells autophagy and apoptosis. These compounds will expand the structural diversity of anti-cancer targets and confirm the prospects for further research.
Studies on the enzyme immunoassay of bio-active constituents contained in oriental medicinal drugs. V. Preparation of bovine serum albumin conjugate and .BETA.-galactosidase labelled antigen for enzyme immunoassay of 3.BETA.-(monoglucuron-1'.BETA.-yl)-18.BETA.-glycyrrhetic acid.
作者:Matao KANAOKA、Hiromi KATO、Saburo YANO
DOI:10.1248/cpb.38.221
日期:——
In order to prepare an immunogen for enzyme immunoassay of 3β-(monoglucuron-1'-β-yl)-18β-glycyrrhetic acid (3MGA), which was isolated from a patient with glycyrrhizin-induced pseudoaldosteronisms, benzyl glycyrrhetate (3) was allowed to react with an acetobromosugar (2) in the presence of silver carbonate to give benzyl 3β-(methyl2', 3', 4'-triacetyl-glucuron-1'β-yl)-glycyrrhetate (5) and methyl 3', 4'-diacetyl-α-1', 2'-O-[1-(benzyl glycyrrhet-3β-yl)-ethylidene]-D-glucuronate (4). On the other hadn, this reaction was carried out in the presence of mercuric cyanide in nitromethane to give compound 5, benzyl 3β-acetryl glycyrrhetate (6) and benzyl 11-oxo-A-neooleana-3(5), 12-dien-3-oate (7). 4-Aminomethylcyclohexanecarboxylic acid and glycine were introduced as chemical bridges at C-30 of 3β-(tertbutylglucuron-1'β-yl)-glycyrrhetic acid (11) derived from compound 5. The former bridge was used to prepare an immunogenic conjugate with bovine serum albumin, and the latter bridge was used for antigen labelled with β-galactosidase.